PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2019The Lancet Psychiatry871 citationsOpen Access

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

MFMarta Di FortiDQDiego QuattroneTFTom P. Freeman

Key Points

  • To investigate how cannabis use contributes to differences in the incidence of psychotic disorders across Europe.
  • Multicentre case-control study design
  • Analysis focused on variation in psychotic disorder incidence in relation to cannabis use
  • Collaboration among multiple research institutions across Europe
  • Found significant variation in psychotic disorder incidence linked to cannabis use
  • Identified specific patterns of cannabis consumption correlating with increased incidence
  • Revealed a potential public health concern regarding cannabis accessibility and mental health

Abstract

Medical Research Council, the European Community's Seventh Framework Program grant, São Paulo Research Foundation, National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College London and the NIHR BRC at University College London, Wellcome Trust.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Forti et al. (2019) studied this question.

synapsesocial.com/papers/69dab4a4615cc0c8eaa3d138https://doi.org/10.1016/s2215-0366(19)30048-3
Ask AI
Helpful
Bookmark
Share
View Full Paper